Rhythm Pharmaceuticals
Price & Volume
Stats
See more52W Range | $74.50-$122.20 |
Market Cap | $7.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $217.1M |
Revenue Growth (YoY) | 83.8% |
Gross Profit (12 Mos) | $194.1M |
Diluted EPS | -$3.13 |
News
See moreYahoo Finance • 16 days ago
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
Yahoo Finance • 17 days ago
Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 414 |